|
Volumn 15, Issue 5, 2004, Pages 839-840
|
Use of red blood cell transfusion in palliative care services: Is it still up to date or is cancer-related anaemia controlled better with erythropoietic agents? [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN;
RECOMBINANT ERYTHROPOIETIN;
ADVANCED CANCER;
ANEMIA;
CANCER PALLIATIVE THERAPY;
CANCER PATIENT;
CLINICAL TRIAL;
DRUG COST;
DRUG EFFICACY;
ERYTHROCYTE TRANSFUSION;
EVIDENCE BASED MEDICINE;
FLUSHING;
HEMOGLOBIN DETERMINATION;
HEMOLYTIC ANEMIA;
HOME CARE;
HUMAN;
IMMUNOPATHOLOGY;
INFECTION;
LETTER;
PRIORITY JOURNAL;
PRURITUS;
QUALITY OF LIFE;
SURVIVAL;
VIRUS INFECTION;
WELLBEING;
ANEMIA;
ERYTHROCYTE TRANSFUSION;
ERYTHROPOIETIN, RECOMBINANT;
HEMATOCRIT;
HUMANS;
NEOPLASMS;
PALLIATIVE CARE;
PROGNOSIS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
|
EID: 2642563845
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdh178 Document Type: Letter |
Times cited : (20)
|
References (8)
|